Subcutaneous Drug Delivery Devices Market
Subcutaneous Drug Delivery Devices Market Forecasts to 2030 - Global Analysis By Product (Prefilled Syringes, Auto-Injectors, Wearable Injectors, Pen Injectors, Needle-Free Injectors and Other Products), Type, Indication, Distribution Channel and By Geography
"According to Stratistics MRC, the Global Subcutaneous Drug Delivery Devices Market is accounted for $42.6 billion in 2026 and is expected to reach $100.2 billion by 2034 growing at a CAGR of 11.3% during the forecast period. Medical equipment called subcutaneous drug delivery devices is used to give patients medication subcutaneously, or under the skin. This method of drug delivery is preferred over others because it enables the drug's constant and continuous release into circulation, leading to less side effects and more consistent therapeutic advantages. Subcutaneous drug delivery systems consist of a syringe inserted under the skin, a distribution system, and a pharmaceutical container.
According to the National Multiple Sclerosis Society, an estimated 1.0 million adults were reported to be living with multiple sclerosis in the U.S. in 2017.
Market Dynamics:
Driver:
Rise in Chronic Diseases
Increasing prevalence of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions has driven the demand for subcutaneous drug delivery devices. These devices offer an effective way to administer medication for long-term management of these ailments. Therefore, the rapidly growing prevalence of chronic diseases is expected to drive the growth of the market.
Restraint:
Lack of health awareness
In emerging and undeveloped economies, there's a dearth of knowledge about pharmaceuticals, various ailments, and drug delivery technologies. Chronic illness-related fatalities rise as a result of inadequate healthcare facilities. Most rural residents continue to go undetected and untreated. Furthermore, the use of subcutaneous drug delivery devices is limited in a number of countries by the high cost of medications and drug administration equipment. This is a significant element that might impede market expansion.
Opportunity:
Growing demand for biosimilar and biologics
The market participants in the worldwide subcutaneous drug delivery devices market have a number of growth opportunities thanks to the quick rise in popularity of biologic and biosimilar medications. Global demand for subcutaneous drug delivery systems is being driven by the increasing need for different medications to treat chronic conditions. The growing use of biologics and biosimilars, which often require subcutaneous administration, has bolstered the demand for specialized delivery devices tailored for these medications.
Threat:
Improper use may give rise to needle stick injuries
Needlestick injuries and drug overdoses are only two of the issues that can arise from using subcutaneous medication delivery devices improperly without the right information and instruction. This can make it more difficult for the patients to choose between several drug delivery options. Furthermore, the dangers of blood-borne infections linked to injection needles might end up being a significant obstacle.
Covid-19 Impact:
The market for subcutaneous medication delivery devices has been significantly impacted by the COVID-19 epidemic, as has the whole healthcare sector. Self-administration devices are becoming more and more in demand as a result of the growing emphasis on home-based treatment, remote healthcare, and reducing hospital visits. The epidemic has brought attention to the significance of efficient medication delivery techniques, spurring innovation and investment in the subcutaneous drug delivery market.
The wearable injectors segment is expected to be the largest during the forecast period
The wearable injectors segment is expected to be the largest during the forecast period. This is linked to the increase in needle stick injuries as well as the increased risk of blood-borne illnesses from injection usage. The high-viscosity, high-volume biologic medications are administered with exceptional efficiency by the wearable injectors. Digital medicine administration tools called wearable injectors are convenient and assist patients in giving precise dosages at the appropriate times.
The neurological disorders segment is expected to have the highest CAGR during the forecast period
The neurological disorders segment is expected to have the highest CAGR during the forecast period. These devices can provide a controlled and steady release of medications over an extended period. For neurological disorders where consistent medication levels are crucial, such as in epilepsy or Parkinson's disease, this controlled release can help manage symptoms effectively. These devices are often designed for patient comfort, minimizing the invasiveness of treatments.
Region with largest share:
North America is projected to hold the largest market share during the forecast period owing to the increased prevalence of various chronic diseases resulted in the huge demand for drugs and drug delivery devices amongst the population. The market is growing due to a number of significant reasons, including the presence of improved healthcare infrastructure, the presence of multiple major manufacturers in the region and the different developmental strategies they have followed, and rising healthcare spending.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period. This is majorly attributed to the rapidly growing diabetic population in the region owing to the unhealthy food habits of the people. The rising disposable income, growing awareness regarding the diabetes management, and rising healthcare expenditure are the major factors that will drive the growth of the market in the forthcoming future.
Key players in the market
Some of the key players in Subcutaneous Drug Delivery Devices market include Medtronic Plc, Gerresheimer AG, Elcam Medical Group, Insulet Corporation, Ypsomed AG, Becton, Dickinson and Company, PharmaJet, Unilife Corporation, In life Sciences , West Pharmaceutical Services, Inc., Novo Nordisk, Eli Lilly, Merck, AstraZeneca, Amgen, Enable Injections, Consort Medical Plc and Wilhelm Haselmeier GmbH & Co. KG.
Key Developments:
In November 2023, The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Zepbound™ (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.
In October 2023, Eli Lilly gives $20M upfront cash injection to Elektrofi in next-gen subcutaneous drug collab. Eli Lilly has tapped up drug delivery specialist Elektrofi to see whether the biotech’s microparticle formulation technology could produce the next generation of subcutaneously administered therapies.
Products Covered:
• Prefilled Syringes
• Auto-Injectors
• Wearable Injectors
• Pen Injectors
• Needle-Free Injectors
• Other Products
Types Covered:
• Disposable
• Reusable
Indications Covered:
• Neurological Disorders
• Oncology Disorders
• Auto-immune Disorders
• Ophthalmic Disorders
• Allergy & Infectious Disorders
• Hormonal Disorders
• Other Indications
Distribution Channels Covered:
• Hospitals
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
"1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Subcutaneous Drug Delivery Devices Market, By Product
5.1 Introduction
5.2 Prefilled Syringes
5.3 Auto-Injectors
5.4 Wearable Injectors
5.5 Pen Injectors
5.6 Needle-Free Injectors
5.7 Other Products
6 Global Subcutaneous Drug Delivery Devices Market, By Type
6.1 Introduction
6.2 Disposable
6.3 Reusable
7 Global Subcutaneous Drug Delivery Devices Market, By Indication
7.1 Introduction
7.2 Neurological Disorders
7.3 Oncology Disorders
7.4 Auto-immune Disorders
7.5 Ophthalmic Disorders
7.6 Allergy & Infectious Disorders
7.7 Hormonal Disorders
7.8 Other Indications
8 Global Subcutaneous Drug Delivery Devices Market, By Distribution Channel
8.1 Introduction
8.2 Hospitals
8.3 Retail Pharmacies
8.4 Online Pharmacies
8.5 Other Distribution Channels
9 Global Subcutaneous Drug Delivery Devices Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Medtronic Plc
11.2 Gerresheimer AG
11.3 Elcam Medical Group
11.4 Insulet Corporation
11.5 Ypsomed AG
11.6 Becton, Dickinson and Company
11.7 PharmaJet
11.8 Unilife Corporation
11.9 In life Sciences
11.10 West Pharmaceutical Services, Inc.
11.11 Novo Nordisk
11.12 Eli Lilly
11.13 Merck
11.14 AstraZeneca
11.15 Amgen
11.16 Enable Injections
11.17 Consort Medical Plc
11.18 Wilhelm Haselmeier GmbH & Co. KG
List of Tables
Table 1 Global Subcutaneous Drug Delivery Devices Market Outlook, By Region (2023–2034) ($MN)
Table 2 Global Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023–2034) ($MN)
Table 3 Global Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023–2034) ($MN)
Table 4 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023–2034) ($MN)
Table 5 Global Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023–2034) ($MN)
Table 6 Global Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023–2034) ($MN)
Table 7 Global Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023–2034) ($MN)
Table 8 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023–2034) ($MN)
Table 9 Global Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023–2034) ($MN)
Table 10 Global Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023–2034) ($MN)
Table 11 Global Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023–2034) ($MN)
Table 12 Global Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023–2034) ($MN)
Table 13 Global Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023–2034) ($MN)
Table 14 Global Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023–2034) ($MN)
Table 15 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023–2034) ($MN)
Table 16 Global Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023–2034) ($MN)
Table 17 Global Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023–2034) ($MN)
Table 18 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023–2034) ($MN)
Table 19 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023–2034) ($MN)
Table 20 Global Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023–2034) ($MN)
Table 21 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023–2034) ($MN)
Table 22 Global Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023–2034) ($MN)
Table 23 Global Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023–2034) ($MN)
Table 24 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023–2034) ($MN)
Table 25 North America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023–2034) ($MN)
Table 26 North America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023–2034) ($MN)
Table 27 North America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023–2034) ($MN)
Table 28 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023–2034) ($MN)
Table 29 North America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023–2034) ($MN)
Table 30 North America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023–2034) ($MN)
Table 31 North America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023–2034) ($MN)
Table 32 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023–2034) ($MN)
Table 33 North America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023–2034) ($MN)
Table 34 North America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023–2034) ($MN)
Table 35 North America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023–2034) ($MN)
Table 36 North America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023–2034) ($MN)
Table 37 North America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023–2034) ($MN)
Table 38 North America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023–2034) ($MN)
Table 39 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023–2034) ($MN)
Table 40 North America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023–2034) ($MN)
Table 41 North America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023–2034) ($MN)
Table 42 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023–2034) ($MN)
Table 43 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023–2034) ($MN)
Table 44 North America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023–2034) ($MN)
Table 45 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023–2034) ($MN)
Table 46 North America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023–2034) ($MN)
Table 47 North America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023–2034) ($MN)
Table 48 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023–2034) ($MN)
Table 49 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023–2034) ($MN)
Table 50 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023–2034) ($MN)
Table 51 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023–2034) ($MN)
Table 52 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023–2034) ($MN)
Table 53 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023–2034) ($MN)
Table 54 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023–2034) ($MN)
Table 55 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023–2034) ($MN)
Table 56 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023–2034) ($MN)
Table 57 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023–2034) ($MN)
Table 58 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023–2034) ($MN)
Table 59 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023–2034) ($MN)
Table 60 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023–2034) ($MN)
Table 61 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023–2034) ($MN)
Table 62 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023–2034) ($MN)
Table 63 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023–2034) ($MN)
Table 64 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023–2034) ($MN)
Table 65 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023–2034) ($MN)
Table 66 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023–2034) ($MN)
Table 67 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023–2034) ($MN)
Table 68 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023–2034) ($MN)
Table 69 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023–2034) ($MN)
Table 70 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023–2034) ($MN)
Table 71 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023–2034) ($MN)
Table 72 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023–2034) ($MN)
Table 73 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023–2034) ($MN)
Table 74 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023–2034) ($MN)
Table 75 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023–2034) ($MN)
Table 76 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023–2034) ($MN)
Table 77 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023–2034) ($MN)
Table 78 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023–2034) ($MN)
Table 79 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023–2034) ($MN)
Table 80 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023–2034) ($MN)
Table 81 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023–2034) ($MN)
Table 82 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023–2034) ($MN)
Table 83 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023–2034) ($MN)
Table 84 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023–2034) ($MN)
Table 85 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023–2034) ($MN)
Table 86 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023–2034) ($MN)
Table 87 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023–2034) ($MN)
Table 88 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023–2034) ($MN)
Table 89 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023–2034) ($MN)
Table 90 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023–2034) ($MN)
Table 91 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023–2034) ($MN)
Table 92 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023–2034) ($MN)
Table 93 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023–2034) ($MN)
Table 94 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023–2034) ($MN)
Table 95 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023–2034) ($MN)
Table 96 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023–2034) ($MN)
Table 97 South America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023–2034) ($MN)
Table 98 South America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023–2034) ($MN)
Table 99 South America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023–2034) ($MN)
Table 100 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023–2034) ($MN)
Table 101 South America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023–2034) ($MN)
Table 102 South America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023–2034) ($MN)
Table 103 South America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023–2034) ($MN)
Table 104 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023–2034) ($MN)
Table 105 South America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023–2034) ($MN)
Table 106 South America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023–2034) ($MN)
Table 107 South America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023–2034) ($MN)
Table 108 South America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023–2034) ($MN)
Table 109 South America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023–2034) ($MN)
Table 110 South America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023–2034) ($MN)
Table 111 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023–2034) ($MN)
Table 112 South America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023–2034) ($MN)
Table 113 South America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023–2034) ($MN)
Table 114 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023–2034) ($MN)
Table 115 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023–2034) ($MN)
Table 116 South America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023–2034) ($MN)
Table 117 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023–2034) ($MN)
Table 118 South America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023–2034) ($MN)
Table 119 South America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023–2034) ($MN)
Table 120 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023–2034) ($MN)
Table 121 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023–2034) ($MN)
Table 122 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023–2034) ($MN)
Table 123 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023–2034) ($MN)
Table 124 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023–2034) ($MN)
Table 125 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023–2034) ($MN)
Table 126 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023–2034) ($MN)
Table 127 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023–2034) ($MN)
Table 128 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023–2034) ($MN)
Table 129 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023–2034) ($MN)
Table 130 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023–2034) ($MN)
Table 131 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023–2034) ($MN)
Table 132 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023–2034) ($MN)
Table 133 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023–2034) ($MN)
Table 134 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023–2034) ($MN)
Table 135 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023–2034) ($MN)
Table 136 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023–2034) ($MN)
Table 137 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023–2034) ($MN)
Table 138 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023–2034) ($MN)
Table 139 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023–2034) ($MN)
Table 140 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023–2034) ($MN)
Table 141 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023–2034) ($MN)
Table 142 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023–2034) ($MN)
Table 143 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023–2034) ($MN)
Table 144 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023–2034) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
